The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
27050842 |
39 |
Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker. |
Northwestern University |
23458846 |
16 |
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers. |
Northwestern University |
21684157 |
68 |
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights. |
Nycomed |
22840695 |
52 |
Discovery of a potent, orally bioavailable and highly selective human neuronal nitric oxide synthase (nNOS) inhibitor, N-(1-(piperidin-4-yl)indolin-5-yl)thiophene-2-carboximidamide as a pre-clinical development candidate for the treatment of migraine. |
Neuraxon |
22335555 |
43 |
1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors: lead optimization studies resulting in the identification of N-(1-(2-(methylamino)ethyl)-1,2,3,4-tetrahydroquinolin-6-yl)thiophene-2-carboximidamide as a preclinical development candidate. |
Neuraxon |
23123728 |
4 |
Synthesis, biological evaluation and molecular docking studies of 3-(triazolyl)-coumarin derivatives: effect on inducible nitric oxide synthase. |
Universidade De S£O Paulo |
24900459 |
53 |
NOpiates: Novel Dual Action Neuronal Nitric Oxide Synthase Inhibitors with µ-Opioid Agonist Activity. |
TBA |
22420844 |
86 |
First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain. |
Neuraxon |
22370270 |
30 |
Novel, druglike 1,7-disubstituted 2,3,4,5-tetrahydro-1H-benzo[b]azepine-based selective inhibitors of human neuronal nitric oxide synthase (nNOS). |
Neuraxon |
21923116 |
40 |
Discovery of N-(3-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-6-yl) thiophene-2-carboximidamide as a selective inhibitor of human neuronal nitric oxide synthase (nNOS) for the treatment of pain. |
Neuraxon |
18083522 |
15 |
N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system. |
Christian-Albrechts-University of Kiel |
18024030 |
110 |
Discovery of a series of aminopiperidines as novel iNOS inhibitors. |
Adolor |
17317165 |
77 |
Novel 2-aminobenzothiazoles as selective neuronal nitric oxide synthase inhibitors. |
Neuraxon |
15357988 |
87 |
Evaluation of pyrrolidin-2-imines and 1,3-thiazolidin-2-imines as inhibitors of nitric oxide synthase. |
Merck Research Laboratory |
15357982 |
18 |
Substituted 6-phenyl-pyridin-2-ylamines: selective and potent inhibitors of neuronal nitric oxide synthase. |
Pfizer |
14761191 |
19 |
5-Fluorinated L-lysine analogues as selective induced nitric oxide synthase inhibitors. |
Pfizer |
12620067 |
47 |
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo. |
Astrazeneca R&D Charnwood |
14667223 |
72 |
Computer modeling of selective regions in the active site of nitric oxide synthases: implication for the design of isoform-selective inhibitors. |
Northwestern University |
11931623 |
6 |
Synthesis and biological characterization of L-N(6)-(1-iminoethyl)lysine 5-tetrazole-amide, a prodrug of a selective iNOS inhibitor. |
Pfizer |
9554868 |
40 |
2-Iminohomopiperidinium salts as selective inhibitors of inducible nitric oxide synthase (iNOS). |
Pfizer |
9733492 |
54 |
2-Iminopyrrolidines as potent and selective inhibitors of human inducible nitric oxide synthase. |
Pfizer |
9667974 |
150 |
N-Phenylamidines as selective inhibitors of human neuronal nitric oxide synthase: structure-activity studies and demonstration of in vivo activity. |
Glaxo Wellcome Research and Development |
9191968 |
88 |
Substituted N-phenylisothioureas: potent inhibitors of human nitric oxide synthase with neuronal isoform selectivity. |
Glaxo Wellcome Research and Development |
8576908 |
33 |
2-Iminopiperidine and other 2-iminoazaheterocycles as potent inhibitors of human nitric oxide synthase isoforms. |
G. D. Searle Research and Development |
12781178 |
33 |
Dihydroquinolines with amine-containing side chains as potent n-NOS inhibitors. |
Schering |
10741561 |
48 |
Inhibition of inducible nitric oxide synthase by acetamidine derivatives of hetero-substituted lysine and homolysine. |
Glaxo Wellcome Research and Development |
22318159 |
36 |
3,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase (nNOS) inhibitors. |
Neuraxon |
22175766 |
45 |
Discovery of cis-N-(1-(4-(methylamino)cyclohexyl)indolin-6-yl)thiophene-2-carboximidamide: a 1,6-disubstituted indoline derivative as a highly selective inhibitor of human neuronal nitric oxide synthase (nNOS) without any cardiovascular liabilities. |
Neuraxon |
22182498 |
71 |
Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors. |
Afraxis |
21699209 |
75 |
Design, synthesis, and biological evaluation of 3,4-dihydroquinolin-2(1H)-one and 1,2,3,4-tetrahydroquinoline-based selective human neuronal nitric oxide synthase (nNOS) inhibitors. |
Neuraxon |
21986586 |
124 |
Identification and SAR of selective inducible nitric oxide synthase (iNOS) dimerization inhibitors. |
Kalypsys |
21824773 |
46 |
1,6-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. |
Neuraxon |
21813276 |
56 |
1,5-Disubstituted indole derivatives as selective human neuronal nitric oxide synthase inhibitors. |
Neuraxon |
20931971 |
155 |
Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNO |
Kalypsys |
21482467 |
28 |
Heteroalicyclic carboxamidines as inhibitors of inducible nitric oxide synthase; the identification of (2R)-2-pyrrolidinecarboxamidine as a potent and selective haem-co-ordinating inhibitor. |
Glaxosmithkline |
21410186 |
43 |
Symmetric double-headed aminopyridines, a novel strategy for potent and membrane-permeable inhibitors of neuronal nitric oxide synthase. |
Northwestern University |
19203270 |
14 |
Synthesis, biological evaluation, and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase. |
Universita G. D'Annunzio |
| 44 |
Inhibition of nitric oxide synthase by benzoxazolones |
TBA |
| 24 |
Conformationally restricted arginine analogues as inhibitors of human nitric oxide synthase |
TBA |
| 10 |
1,2-diaminobenzimidazoles : Selective inhibitors of nitric oxide synthase derived from aminoguanidine |
TBA |
19323559 |
19 |
Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase. |
Washington University |
16033258 |
51 |
Structural analysis of isoform-specific inhibitors targeting the tetrahydrobiopterin binding site of human nitric oxide synthases. |
Sanofi-Aventis |
15911272 |
21 |
Evaluation of 3-substituted arginine analogs as selective inhibitors of human nitric oxide synthase isozymes. |
Nagoya City University |
15808455 |
39 |
Bicyclic amidine inhibitors of nitric oxide synthase: discovery of perhydro-iminopyrindine and perhydro-iminoquinoline as potent, orally active inhibitors of inducible nitric oxide synthase. |
Merck Research Laboratories |
15501067 |
51 |
Synthesis of analogs of (1,4)-3- and 5-imino oxazepane, thiazepane, and diazepane as inhibitors of nitric oxide synthases. |
Merck Research Laboratories |
15163211 |
51 |
2-aminopyridines as highly selective inducible nitric oxide synthase inhibitors. Differential binding modes dependent on nitrogen substitution. |
Astrazeneca R&D Charnwood |
14998342 |
73 |
Structure-activity relationships of potent, selective inhibitors of neuronal nitric oxide synthase based on the 6-phenyl-2-aminopyridine structure. |
Pfizer |
14741281 |
36 |
Fluorinated dihydroquinolines as potent n-NOS inhibitors. |
Schering |
12392746 |
18 |
3-Hydroxy-4-methyl-5-pentyl-2-iminopyrrolidine: a potent and highly selective inducible nitric oxide synthase inhibitor. |
Pharmacia |
12182860 |
72 |
Dihydroquinolines as novel n-NOS inhibitors. |
Schering |
12161118 |
28 |
Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: synthesis and biological evaluation of dihydropyridin-2-imines. |
Fukui Research Institute |
11551770 |
40 |
Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase. |
Pharmacia |
32676156 |
8 |
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation. |
University "G. D'Annunzio" of Chieti-Pescara |
11327581 |
44 |
Thienopyridines: nitric oxide synthase inhibitors with potent in vivo activity. |
Astrazeneca R&D Charnwood |
11327580 |
73 |
3,4-Dihydro-1-isoquinolinamines: a novel class of nitric oxide synthase inhibitors with a range of isoform selectivity and potency. |
Astrazeneca R&D Charnwood |
10987430 |
86 |
Substituted 2-aminopyridines as inhibitors of nitric oxide synthases. |
Merck Research Laboratories |
30802056 |
63 |
Optimization of Blood-Brain Barrier Permeability with Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibitors Having a 2-Aminopyridine Scaffold. |
Northwestern University |
10498210 |
27 |
A new class of selective and potent inhibitors of neuronal nitric oxide synthase. |
Pfizer |
10346937 |
15 |
Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase. |
Wake Forest University |
32302123 |
114 |
First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate. |
Northwestern University |
9526553 |
6 |
Acetamidine lysine derivative, N-(5(S)-amino-6,7-dihydroxyheptyl)ethanimidamide dihydrochloride: a highly selective inhibitor of human inducible nitric oxide synthase. |
Searle |
9438025 |
54 |
Substituted 2-iminopiperidines as inhibitors of human nitric oxide synthase isoforms. |
G. D. Searle Research and Development |
8978842 |
9 |
Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers. |
Washington University |
28422508 |
78 |
Nitrile in the Hole: Discovery of a Small Auxiliary Pocket in Neuronal Nitric Oxide Synthase Leading to the Development of Potent and Selective 2-Aminoquinoline Inhibitors. |
Northwestern University |
28776992 |
110 |
Hydrophilic, Potent, and Selective 7-Substituted 2-Aminoquinolines as Improved Human Neuronal Nitric Oxide Synthase Inhibitors. |
Northwestern University |
29091437 |
50 |
Improvement of Cell Permeability of Human Neuronal Nitric Oxide Synthase Inhibitors Using Potent and Selective 2-Aminopyridine-Based Scaffolds with a Fluorobenzene Linker. |
Northwestern University |
24497639 |
38 |
Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1. |
Bayer Healthcare |
12784105 |
53 |
Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. |
Case Western Reserve University |
8863838 |
28 |
Coupling of metabotropic glutamate receptors 2 and 4 to G alpha 15, G alpha 16, and chimeric G alpha q/i proteins: characterization of new antagonists. |
Upr Centre |
7891350 |
9 |
Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist. |
Parke-Davis Pharmaceutical Research |
15027867 |
10 |
Inactivation of purified human recombinant monoamine oxidases A and B by rasagiline and its analogues. |
Emory University |